Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells

Journal of Immunology

Volumn 172, Issue 6, 2004, Pages 3712-3718

  Netea, Mihai G ^a   Sutmuller, Roger ^a   Hermann, Corinna ^b   Van Der Graaf, Chantal A A ^a   Van Der Meer, Jos W M ^a   Van Krieken, Johan H ^a   Hartung, Thomas ^b   Adema, Gosse ^a   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FUNGICIDAL ACTIVITY; HOST RESISTANCE; IMMUNITY; IN VITRO STUDY; INFECTION RESISTANCE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 1542409922     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.6.3712     Document Type: Article

References (34)

1. Pfaller, M. A., R. N. Jones, G. V. Doern, A. C. Fluit, J. Verhoef, H. S. Sader, S. A. Messer, A. Houston, S. Coffman, R. J. Hollis, and SENTRY Participant Group (Europe). 1999. International surveillance of bloodstream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn. Microbiol. Infect. Dis. 35:19.
2. Edmond, M. B., S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, and R. P. Wenzel. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29:239.
3. Netea, M. G., C. de Graaf, A. Vonk, I. Verschueren, J. W. M. Van der Meer, and B. J. Kullberg. 2002. The role of Toll-like receptors in the defense against disseminated candidiasis. J. Infect. Dis. 185:1483.
4. Underhill, D. M., A. Ozinski, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811.
5. Takeuchi, O., K. Hoshino, and S. Akira. 2000. TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus infection. J. Immunol. 165:5392.
6. Koedel, U., B. Angele, T. Rupprecht, H. Wagner, A. Roggenkamp, H.-W. Pfister, and C. J. Kirschning. 2003. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170:438.
7. Echchannaoui, H., K. Frei, C. Schnell, S. L. Leib, W. Zimmerli, and R. Landmann. 2002. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186:798.
8. Qureshi, S. T., and R. Medzhitov. 2003. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun. 4:87.
9. Lehrer, R. I., and M. J. Cline. 1969. Interactions of Candida albicans with human leukocytes and serum. J. Bacteriol. 98:996.
10. Kullberg, B. J., J. W. Van't Wout, and R. Van Furth. 1990. Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun. 58:3319.
11. Kullberg, B. J., J. W. Van't Wout, C. Hoogstraten, and R. Van Furth. 1993. Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis. 168:436.
12. Vonk, A. G., C. W. Wieland, M. G. Netea, and B. J. Kullberg. 2002. Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems. J. Microbiol. Methods 49:55.
13. Vonk, A. G., M. G. Netea, J. H. van Krieken, J. W. M. Van der Meer, and B. J. Kullberg. 2002. Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-α and lymphotoxin-α deficient mice. J. Infect. Dis. 186:1815.
14. Netea, M. G., P. N. M. Demacker, B. J. Kullberg, O. C. Boerman, I. Verschueren, A. F. H. Stalenhoef, and J. W. M. Van der Meer. 1996. Low-density-lipoprotein receptor deficient mice are protected against lethal endotoxinemia and severe Gram-negative infections. J. Clin. Invest. 97:1366.
15. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169:6298.
16. Tada, H., E. Nemoto, H. Shimauki, T. Watanabe, T. Mikami, T. Matsumoto, N. Ohna, H. Tamura, K. Shibata, S. Akashi. et al. 2002. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor α by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol. Immunol. 2002:503.
17. Netea, M. G., L. J. H. Van Tits, J. H. A. J. Curfs, F. Amiot, J. F. G. M. Meis, J. W. M. Van der Meer, and B. J. Kullberg. 1999. The increased susceptibility of TNFα LTα double knock-out mice to systemic candidiasis is due to defective recruitment and phagocytosis by neutrophils. J. Immunol. 163:1498.
18. Yamamoto, Y., T. W. Klein, and H. Friedman. 1997. Involvement of mannose receptor in cytokine interleukin-1β (IL-1β), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1β (MIP-1β), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect. Inimun. 65:1077.
19. Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, S. Y. C. Wong, and S. Gordon. 2002. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196:407.
20. Forsyth, C. B., and H. L. Mathews. 1996. Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans. Cell. Immunol. 170:91.
21. Cambi, A., K. Gijzen, J. de Vries, R. Torensma, B. Joosten, G. J. Adema, M. G. Netea, B. J. Kullberg, L. Romani, and C. G. Figdor. 2003. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 33:532.
22. Brown, G. D., J. Herre, D. L. Williams, J. A. Willment, A. S. Marshall, and S. Gordon. 2003. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197:1119.
23. Gantner, B. N., R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:1107.
24. Romani, L., P. Puccetti, A. Mencacci, E. Cenci, R. Spaccapelo, L. Tonnetti, U. Grohmann, and F. Bistoni. 1994. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152:3514.
25. Vasquez-Torres, A., J. Jones-Carson, R. D. Wagner, T. Warner, and E. Balish. 1999. Early resistance of interleukin-10 knock-out mice to acute systemic candidiasis. Infect. Immun. 67:670.
26. Re, F., and J. L. Strominger. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human denderitic cells. J. Biol. Chem. 276:37692.
27. Sing, A., D. Rost, N. Tvardovskaia, A. Roggenkamp, A. Wiedemann, C. J. Kirschning, M. Aepfelbacher, and J. Heesemann. 2002. Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin-10-mediated immunosuppression. J. Exp. Med. 196:1017.
28. + Tr cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111.
29. Van der Kleij, D., E. Latz, J. F. H. M. Brouwers, Y. C. M. Kruize, M. Schmitz, E. A. Kurt-Jones, T. Espevik, E. C. de Jong, M. L. Kapsenberg, D. T. Golenbock, et al. 2002. A novel host-parasite lipid cross talk: schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277:48122.
30. + T cell-mediated suppression by dendritic cells. Science 299:1033.
31. + regulatory T cells control Leishmania major persistence and immunity. Nature 420:502.
32. Fulurija, A., R. B. Ashman, and J. M. Papadimitriou. 1997. Increased tissue resistance in the nude mice against Candida albicans without altering strain-dependent differences in susceptibility. J. Med. Vet. Mycol. 35:197.
33. Tavares, D., P. Ferreira, and M. Arala-Chaves. 2000. Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J. Infect. Dis. 182:266.
34. + cells in acute, systemic murine candidosis. J. Leukocyte Biol. 51:305.